Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved a drug for the treatment of heart failure specifically in self-identified black patients, the first time an approval has targeted a racial group. In an announcement, the FDA said the approval represented a step toward the “promise of personalized medicine.”

FDA approves heart failure drug specifically for black patients